ISIN | CH0271797331 |
---|---|
Valor Number | 27179733 |
Bloomberg Global ID | VAKSFEH SW |
Fund Name | VVA - Aktien Schweiz F (EUR hedged) |
Fund Provider |
UBS Switzerland AG, Zurich
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Other Funds |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 152.86 EUR | 05.06.2025 |
---|---|---|
Previous Price * | 152.61 EUR | 04.06.2025 |
52 Week High * | 159.44 EUR | 20.03.2025 |
52 Week Low * | 132.74 EUR | 09.04.2025 |
NAV * | 152.86 EUR | 05.06.2025 |
Issue Price * | 152.86 EUR | 05.06.2025 |
Redemption Price * | 152.86 EUR | 05.06.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 2,008,073,023 | |
Unit/Share Assets *** | 14,825,880 | |
Trading Information SIX |
YTD Performance | +9.14% |
31.12.2024 - 05.06.2025
31.12.2024 05.06.2025 |
---|---|---|
YTD Performance (in CHF) | +8.96% |
31.12.2024 - 05.06.2025
31.12.2024 05.06.2025 |
1 month | +0.82% |
05.05.2025 - 05.06.2025
05.05.2025 05.06.2025 |
3 months | -3.69% |
05.03.2025 - 05.06.2025
05.03.2025 05.06.2025 |
6 months | +7.37% |
05.12.2024 - 05.06.2025
05.12.2024 05.06.2025 |
1 year | +5.27% |
05.06.2024 - 05.06.2025
05.06.2024 05.06.2025 |
2 years | +15.66% |
05.06.2023 - 05.06.2025
05.06.2023 05.06.2025 |
3 years | +18.17% |
07.06.2022 - 05.06.2025
07.06.2022 05.06.2025 |
5 years | +34.00% |
05.06.2020 - 05.06.2025
05.06.2020 05.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 5.83% | |
---|---|---|
Roche Holding AG | 4.61% | |
Nestle SA | 4.31% | |
Zurich Insurance Group AG | 3.08% | |
ABB Ltd | 2.12% | |
Compagnie Financiere Richemont SA Class A | 2.10% | |
Holcim Ltd | 2.00% | |
Alcon Inc | 1.53% | |
Lonza Group Ltd | 1.45% | |
Last data update | 30.04.2025 |
TER | 0.53% |
---|---|
TER date | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.50% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |